Loading clinical trials...

A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening | Clinical Trials | Clareo Health

RECRUITING

A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening

Integrating Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening; Structural Cardiac Assessment With Networked AI-ECG & FOCUS (SCAN) Study

NCT06891222•Mayo Clinic

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate and compare the effectiveness of active screening for SHD in asymptomatic outpatients referred for an ECG, using a combination of AI-ECG and FOCUS. Invites will be sent and participants enrolled electronically.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Adult patients (\>18 years of age)
•Echocardiogram is not clinically indicated

Exclusion Criteria

•Prior history of congenital or acquired SHD, as defined by the following
•1. Aortic Stenosis:
•2. Heart Failure
•3. Left Ventricular Dysfunction
•4. Cardiac Amyloidosis
•5. Hypertrophic Cardiomyopathy (HCM)
•6. Rheumatic Heart Disease
•7. Congenital Heart Disease
•Recent (within last 12 months) echocardiogram
•Scheduled clinically indicated future echocardiogram
+1 more criteria

Locations (1)

Mayo Clinic

Rochester, Minnesota, United States

Key Dates

Start Date

April 14, 2025

Primary Completion Date

April 1, 2026

Completion Date

April 1, 2026

Last Updated

May 9, 2025

Enrollment

10,500

ESTIMATED participants

Conditions

Cardiac Disease

Interventions

AI-ECG (artificial intelligence-enabled electrocardiogram)

DIAGNOSTIC_TEST

Focus Screening (focused cardiac ultrasonography)

DIAGNOSTIC_TEST

Contacts

Catalina Paraschiv, M.D., Ph.D.

CONTACT

507-293-3800 Paraschiv.Catalina@mayo.edu

Gal Tsaban, M.D., Ph.D.

CONTACT

507-284-2129 Tsaban.Gal@mayo.edu

Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery

NCT07032792

Cardiac DiseaseSurgery+1 more

View study

RECRUITING

The Clinical Value of Deep Learning-Based Reconstruction Techniques in Cardiac MRI Scanning

NCT07274436

Cardiac Disease

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 9, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening

Inclusion Criteria

Exclusion Criteria

Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery

The Clinical Value of Deep Learning-Based Reconstruction Techniques in Cardiac MRI Scanning

Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging

Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART

Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease

Cardiac Performance System Data Collection Study - Minnesota